Digital pathology technology set to transform medical diagnosis

The FDA on Mon­day fi­nal­ized a long-await­ed rule that out­lines how it will reg­u­late lab­o­ra­to­ry-de­vel­oped tests (LDTs) as med­ical de­vices, even though some crit­ics say the

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes